Other Specified and Unspecified Depressive Disorders
(formerly Depressive Disorder NOS)

Other Specified and Unspecified Depressive Disorders are diagnostic categories defined by the DSM-5 to classify clinical conditions with significant depressive symptoms that do not fully meet the criteria for any of the codified depressive syndromes (such as Major Depressive Disorder, Dysthymia, or Premenstrual Dysphoric Disorder). This category replaces the Depressive Disorder Not Otherwise Specified (NOS) definition from the DSM-IV-TR, a label still widely used in everyday clinical practice.

The DSM-5 distinguishes two subcategories within this general definition:

• Other specified depressive disorder: used when the clinician chooses to indicate the specific reason the full criteria are not met (e.g., insufficient duration, insufficient number of symptoms).
• Unspecified depressive disorder: used when the clinician does not wish or is unable to specify the reason why diagnostic criteria are not fully met, or when insufficient information is available (e.g., emergency settings).

Both labels are appropriate only when the clinical picture is clearly depressive and leads to significant impairment in the person’s overall functioning.

Etiology

The etiology of atypical depressive disorders reflects that of major and structured forms, and results from the interaction of multiple factors:

• Genetic factors, with varying degrees of family predisposition.
• Neurochemical alterations, particularly involving the serotonergic, noradrenergic, and dopaminergic systems.
• Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis, with cortisol changes and altered stress regulation.
• Neuroendocrine imbalances, such as in hypothyroidism or gonadal dysfunction.
• Psychological and traumatic factors, especially during childhood and adolescence.

Pathogenesis and Pathophysiology

Atypical or subsyndromal depressive forms are believed to derive from milder yet chronic and pervasive alterations in the neurobiological pathways involved in mood regulation. Key alterations include:

• Dysregulation of the limbic system and medial prefrontal cortex.
• Reduced activity of mesolimbic dopaminergic circuits (motivation and reward).
• Altered neurovegetative responses to environmental stimuli (sleep-wake cycles, appetite, emotional reactivity).

These anomalies clinically result in unstable emotional functioning, vulnerability to stress, and mood fluctuations that, though subtle, can significantly impact the patient's quality of life.

Risk Factors

Other specified and unspecified depressive disorders share many known risk factors with more structured mood disorders, even in the absence of complete syndromic features. Key factors include:

• Family history of mood disorders, especially depressive or bipolar types.
• Recent or chronic stressful events (bereavement, separation, illness, relational trauma).
• Psychiatric comorbidities, such as anxiety disorders, personality disorders (especially borderline), or eating disorders.
• Insecure attachment styles and difficulty with emotional regulation.
• Certain chronic medical conditions, such as cancer, endocrine disorders, or neurological diseases.

Clinical Manifestations

Subsyndromal depressive forms are highly heterogeneous. The symptomatology resembles that of major depressive episodes but is attenuated or diagnostically incomplete. Patients may report:

• Persistent or fluctuating low mood
• Fatigue and low energy
• Loss of interest or pleasure in usual activities
• Sleep or appetite disturbances
• Low self-esteem, indecisiveness, feelings of emptiness or worthlessness

In some forms, such as premenstrual dysphoria or recurrent brief depression, symptoms may follow specific temporal patterns. At times, anxiety, irritability, or affective lability predominate over clearly depressed mood.

Diagnosis and Diagnostic Criteria

DSM-5 recommends using the label “other specified depressive disorder” when the clinician wishes to specify why criteria for major depressive disorder, dysthymia, or another depressive disorder are not met. Examples of clinical presentations include:

• Recurrent brief depression: episodes of depressed mood lasting between 2 and 13 days, occurring at least once a month for 12 consecutive months.
• Minor depression: depressive episodes lasting more than 2 weeks, but with fewer than 5 symptoms (thus not meeting the criteria for major depressive episode).
• Attenuated premenstrual dysphoric disorder: dysphoric symptoms during the luteal phase of the menstrual cycle, but with incomplete criteria compared to the full form.
• Postpsychotic depressive disorder of schizophrenia: depressive episode arising after remission of a psychotic phase, without fully meeting criteria for major depressive disorder.

When the clinical form is unclear or not specified, the “unspecified depressive disorder” category is used—typical in psychiatric emergency settings, incomplete evaluations, complex cross-cultural contexts, or atypical presentations.

Treatment, Prognosis, and Complications

Treatment of other specified and unspecified depressive disorders requires a personalized approach, taking into account severity, chronicity, functional impact, and comorbidities. In the absence of specific guidelines, treatment follows principles applied to major depressive episodes, with necessary adjustments:

• Psychological therapy: often the first recommended approach, especially in mild or subthreshold forms. Effective techniques include cognitive-behavioral therapy, interpersonal therapy, and mindfulness-based therapy.
• Pharmacological therapy: indicated when there is significant functional impairment, major anxiety comorbidity, or psychotherapy failure. First-line medications include SSRIs, SNRIs, or atypical antidepressants like bupropion. Mood stabilizers may help in cyclic forms.
• Psychoeducation: essential for early symptom recognition, relapse management, and treatment adherence.
• Integrative strategies: regular exercise, sleep hygiene, and family support have shown effectiveness in improving clinical outcomes.

Prognosis is generally favorable in transient and contextual forms but may be complicated by:

• Chronic progression of the disorder (e.g., development into dysthymia or chronic major depressive disorder)
• Frequent recurrence of episodes (especially in recurrent brief depression)
• Comorbidity with personality disorders, anxiety, or substance abuse

These disorders may also represent a prodromal or attenuated form of major affective syndromes, particularly bipolar disorder (especially type II). Continuous monitoring of clinical evolution is therefore essential.

Main complications of other specified and unspecified depressive disorders include:

• Progression to major depressive disorders, particularly if symptoms are persistent and underestimated
• Impaired social, academic, and occupational functioning, even without full criteria for a major episode
• Increased suicide risk, especially in chronic attenuated depression with feelings of emptiness and hopelessness
• Comorbidity with anxiety, somatoform, or personality disorders, complicating diagnosis and treatment response

References
1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). American Psychiatric Publishing. Vol. 5, 2013.
2. American Psychiatric Association. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, Text Revision. American Psychiatric Publishing. Vol. 4, 2000.
3. First MB et al. Structured Clinical Interview for DSM-5 Disorders (SCID-5). American Psychiatric Association Publishing. 2015.
4. Zimmerman M et al. Why some depressive disorders are not diagnosed in psychiatric practice. Comprehensive Psychiatry. Vol. 47, No. 5, 2006, pp. 324–328.
5. Angst J et al. The Hypomania Checklist (HCL-32): a tool for detecting bipolar II disorder. Journal of Affective Disorders. Vol. 88, No. 2, 2005, pp. 217–233.
6. Pini S et al. Depression in the medically ill: diagnosis, biology and treatment. CNS Drugs. Vol. 19, No. 7, 2005, pp. 537–555.
7. Fava GA et al. Subthreshold mood disorders: a clinical and therapeutic challenge. Psychotherapy and Psychosomatics. Vol. 73, No. 5, 2004, pp. 257–267.
8. Benazzi F. Minor depressive disorder and subthreshold depression: review of the literature. Acta Psychiatrica Scandinavica. Vol. 106, No. 6, 2002, pp. 402–408.
9. Rucci P et al. Subthreshold psychiatric disorders in the community: prevalence and impact on the use of health services. Social Psychiatry and Psychiatric Epidemiology. Vol. 38, No. 11, 2003, pp. 597–603.
10. Kessler RC et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. Vol. 289, No. 23, 2003, pp. 3095–3105.